Risk of Pancreatitis With Incretin Therapies Versus Thiazolidinediones in the Veterans Health Administration
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Risk of Pancreatitis With Incretin Therapies Versus Thiazolidinediones in the Veterans Health Administration
Authors
Keywords
-
Journal
ANNALS OF PHARMACOTHERAPY
Volume -, Issue -, Pages -
Publisher
SAGE Publications
Online
2023-10-26
DOI
10.1177/10600280231205490
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials
- (2021) Suetonia C Palmer et al. BMJ-British Medical Journal
- Sex-Related Differences of Acute and Chronic Pancreatitis in Adults
- (2021) Madeline Drake et al. Journal of Clinical Medicine
- Dipeptidyl Peptidase (DPP)-IV Inhibitors with Antioxidant Potential Isolated from Natural Sources: A Novel Approach for the Management of Diabetes
- (2021) Anand-Krishna Singh et al. Pharmaceuticals
- Global Incidence of Acute Pancreatitis Is Increasing Over Time: A Systematic Review and Meta-Analysis
- (2021) Jordan P. Iannuzzi et al. GASTROENTEROLOGY
- The protective role of DPP4 inhibitors in atherosclerosis
- (2020) Hengdao Liu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Thiazolidinediones: the Forgotten Diabetes Medications
- (2019) Harold E. Lebovitz Current Diabetes Reports
- An overview of GLP-1 agonists and recent cardiovascular outcomes trials
- (2019) Kelsey H Sheahan et al. POSTGRADUATE MEDICAL JOURNAL
- The Risk of Acute Pancreatitis After Initiation of Dipeptidyl Peptidase 4 Inhibitors: Testing a Hypothesis of Subgroup Differences in Older U.S. Adults
- (2018) Jin-Liern Hong et al. DIABETES CARE
- Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial
- (2018) Patrick M O'Neil et al. LANCET
- GLP-1 receptor agonists and cardiovascular outcome trials: An update
- (2018) Eirini Andrikou et al. Hellenic Journal of Cardiology
- Association between dipeptidyl peptidase-4 inhibitor drugs and risk of acute pancreatitis
- (2017) Shimin Chen et al. MEDICINE
- Infection increases mortality in necrotizing pancreatitis: A systematic review and meta-analysis
- (2016) Mikkel Werge et al. PANCREATOLOGY
- Association Between Incretin-Based Drugs and the Risk of Acute Pancreatitis
- (2016) Laurent Azoulay et al. JAMA Internal Medicine
- Sitagliptin increases acute pancreatitis risk within 2 years of its initiation: A retrospective cohort analysis of the National Health Insurance database in Taiwan
- (2015) Chin-Hsiao Tseng ANNALS OF MEDICINE
- Incretin-based drugs and risk of acute pancreatitis: A nested-case control study within a healthcare database
- (2015) Davide Soranna et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- A systematic review of acute pancreatitis as an adverse event of type 2 diabetes drugs: from hard facts to a balanced position
- (2014) C. B. Giorda et al. DIABETES OBESITY & METABOLISM
- Risk of pancreatitis in patients treated with incretin-based therapies
- (2014) Juris J. Meier et al. DIABETOLOGIA
- American College of Gastroenterology Guideline: Management of Acute Pancreatitis
- (2013) Scott Tenner et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- A pooled analysis of exenatide use and risk of acute pancreatitis
- (2013) David D. Dore et al. CURRENT MEDICAL RESEARCH AND OPINION
- Glucagonlike Peptide 1–Based Therapies and Risk of Hospitalization for Acute Pancreatitis in Type 2 Diabetes Mellitus
- (2013) Sonal Singh et al. JAMA Internal Medicine
- Drug induced pancreatitis
- (2010) Claudia J. Nitsche et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Acute pancreatitis: Etiology and common pathogenesis
- (2009) Guo-Jun Wang et al. WORLD JOURNAL OF GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started